Large tandem duplications in cancer result from transcription and DNA replication collision

Despite the abundance of somatic structural variations (SVs) in cancer, the underlying molecular mechanisms of their formation remain unclear. Here, we use 6,193 whole-genome sequenced tumors to study the contributions of transcription and DNA replication collisions to genome instability. After deconvoluting robust SV signatures in three independent pan-cancer cohorts, we detect transcription-dependent replicated-strand bias, the expected footprint of transcription-replication collision (TRC), in large tandem duplications (TDs). Large TDs are abundant in female-enriched, upper gastrointestinal tract and prostate cancers. They are associated with poor patient survival and mutations in TP53, CDK12, and SPOP. Upon inactivating or suppressing CDK12, cells display significantly more TRCs and R-loops. Inhibition of WEE1, a cell cycle regulator that promotes DNA repair, selectively inhibits the growth of cells with loss of CDK12. Our data suggest that large TDs in cancer form due to TRC, and their presence can be used as a biomarker for prognosis and treatment.

[1]  Rebecca A Dagg,et al.  Targeting DNA damage response pathways in cancer , 2022, Nature Reviews Cancer.

[2]  Yang Yang,et al.  Starfish infers signatures of complex genomic rearrangements across human cancers , 2022, Nature Cancer.

[3]  Lydia Y. Liu,et al.  A pan-cancer compendium of chromosomal instability , 2022, Nature.

[4]  C. Steele,et al.  Signatures of copy number alterations in human cancer , 2021, Nature.

[5]  G. Legube,et al.  R-loops as Janus-faced modulators of DNA repair , 2021, Nature Cell Biology.

[6]  Erik N. Bergstrom,et al.  Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor , 2020, bioRxiv.

[7]  P. Cramer,et al.  CDK12 globally stimulates RNA polymerase II transcription elongation and carboxyl-terminal domain phosphorylation , 2020, Nucleic acids research.

[8]  Steven J. M. Jones,et al.  Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes , 2020, Nature Cancer.

[9]  A. Ashworth,et al.  Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. , 2020, Cancer discovery.

[10]  Nuno A. Fonseca,et al.  Patterns of somatic structural variation in human cancer genomes , 2020, Nature.

[11]  R. Schiff,et al.  FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer , 2019, Proceedings of the National Academy of Sciences.

[12]  C. Friedel,et al.  CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes , 2019, EMBO reports.

[13]  Daniel S. Day,et al.  CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation , 2018, Nature Communications.

[14]  P. Sharp,et al.  Cdk12 regulates DNA repair genes by suppressing intronic polyadenylation , 2018, Nature.

[15]  Ashley R. Woodfin,et al.  Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy , 2018, Cell.

[16]  S. Sleijfer,et al.  Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.

[17]  F. Markowetz,et al.  Copy-number signatures and mutational processes in ovarian carcinoma , 2017, Nature Genetics.

[18]  Christopher W. Whelan,et al.  Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing , 2018, Cell.

[19]  Joshua M. Stuart,et al.  Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer , 2018, Cell.

[20]  A. Chinnaiyan,et al.  Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer , 2018, Cell.

[21]  Ville Mustonen,et al.  The repertoire of mutational signatures in human cancer , 2018, Nature.

[22]  M. O’Connor,et al.  Targeting the replication stress response in cancer. , 2018, Pharmacology & therapeutics.

[23]  T. Halazonetis,et al.  Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress , 2018, Nature.

[24]  R. Verhaak,et al.  The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations , 2017, bioRxiv.

[25]  Edison T. Liu,et al.  Mechanism of tandem duplication formation in BRCA1 mutant cells , 2017, Nature.

[26]  Icgc,et al.  Pan-cancer analysis of whole genomes , 2017, bioRxiv.

[27]  D. Backos,et al.  Targeting WEE1 Kinase in Cancer. , 2016, Trends in pharmacological sciences.

[28]  S. Lewis,et al.  The Nature of Mutations Induced by Replication-Transcription Collisions , 2016, Nature.

[29]  David C. Jones,et al.  Landscape of somatic mutations in 560 breast cancer whole genome sequences , 2016, Nature.

[30]  Tatiana Popova,et al.  Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications. , 2016, Cancer research.

[31]  Steven J. M. Jones,et al.  Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.

[32]  A. Aguilera,et al.  Replication stress and cancer , 2015, Nature Reviews Cancer.

[33]  Manolis Kellis,et al.  BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair , 2015, Molecular cell.

[34]  Thanos D Halazonetis,et al.  DNA replication stress as a hallmark of cancer. , 2015, Annual review of pathology.

[35]  Neva C. Durand,et al.  A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.

[36]  J. Joung,et al.  Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage , 2014, Genes & development.

[37]  Lovelace J. Luquette,et al.  Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes , 2013, Cell.

[38]  A. Aguilera,et al.  BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2 , 2014, Nature.

[39]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[40]  T. Helleday,et al.  Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress , 2013, Oncogene.

[41]  Luke A. Gilbert,et al.  CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.

[42]  Yu Zhang,et al.  Mechanisms of Programmed DNA Lesions and Genomic Instability in the Immune System , 2013, Cell.

[43]  S. Gabriel,et al.  Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability , 2012, Genome research.

[44]  M. Marra,et al.  Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II , 2012, Molecular and Cellular Biology.

[45]  Ty C. Voss,et al.  DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes , 2012, Nature.

[46]  A. Helmrich,et al.  Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. , 2011, Molecular cell.

[47]  Jernej Ule,et al.  The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. , 2011, Genes & development.

[48]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[49]  J. Lis,et al.  CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. , 2010, Genes & development.

[50]  Aaron Bensimon,et al.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication , 2006, Nature.

[51]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[52]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[53]  G. Wahl,et al.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.

[54]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[55]  A. Giaccia,et al.  The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Deferasirox Exjade,et al.  Clinical Development , 2019 .